LisaMNijmMDJD

Ophthalmology • Warrenville, IL

Cornea & External Disease, Refractive Surgery

Medical Director & Founder Warrenville EyeCare & LASIK

Join to view full profile

Dr. Nijm is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Nijm's full profile

Already have an account?

Office
2S631 Route 59
Warrenville, IL 60555
Phone+1 630-393-7100

Education & Training

University of California Davis HealthFellowship, Cornea, External Diseases, and Refractive Surgery, 2008 - 2009
University of Illinois College of Medicine at ChicagoResidency, Ophthalmology, 2005 - 2008
Southern Illinois UniversityInternship, Internal Medicine, 2004 - 2005
Southern Illinois University School of MedicineClass of 2004

Certifications & Licensure

CA State Medical License 2008 - Present
IL State Medical License 2010 - 2026
American Board of Ophthalmology Ophthalmology

Publications & Presentations

PubMed

1 citations
Long-Term Outcomes of 6-Week Treatment of Lotilaner Ophthalmic Solution, 0.25%, for Demodex Blepharitis: A Noninterventional Extension Study.
Ehsan Sadri, James D Paauw, Joseph B Ciolino, Lisa Nijm, Blake Simmons
Cornea. 2024-11-01
Effectiveness and safety of a novel crosslinked hyaluronate canalicular gel occlusive device for dry eye.
Mark Packer, Richard Lindstrom, Vance Thompson, Jai G Parekh, Preeya Gupta
Journal of Cataract and Refractive Surgery. 2024-10-01
Early Real-World Patient and Staff Experience with an Intracanalicular Dexamethasone Insert.
Lisa Nijm, Cynthia Matossian, Michelle K Rhee, John D Stephens, Maria E Rosselson
Clinical Ophthalmology. 2024-01-01

Press Mentions

Bausch + Lomb Announces New Scientific Data, Educational Events at ESCRSAugust 30th, 2024
Tarsus to Present Saturn-2 Pivotal Phase 3 Trial Data and Saturn-1 Extension Study Long-Term Safety Data Evaluating TP-03 for the Treatment of Demodex Blepharitis at Upcoming Eye Care MeetingsSeptember 27th, 2022
Legal Implications of off-Label UseSeptember 10th, 2018
Join now to see all

Professional Memberships

American Academy of Ophthalmology - AAO
Member